Acta Pharmaceuticals
$37.4Mtotal raised · 2 rounds on record
$24Mlatest round · Seed · Oct 2026 · this month
10+team · employees, estimated range
2022founded
Overview
Early intervention. The next frontier in Alzheimer's disease.
Funding and backers
Total raised
$37.4M
2 rounds on record
Latest round
$24M
Seed · Oct 2026 · this month
Team
11-50
employees, estimated range
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 15
Raised a round Seed $24M · BioSpace
Mar 29, 2023
Raised a round Venture round $13.4M · SEC Form D
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Oct 2026 | $24M | — | BioSpace |
| Venture round | Mar 2023 | $13.4M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Acta Pharmaceuticals, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
George AlexExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We enable early intervention for high-risk individuals with complex diabetes through advanced remote monitoring and personalized support.
Streamline behavioral health with data, insights & workflows. Improve care coordination, early intervention & outcomes. Request a demo…
"There is still no cheap and effective way to diagnose the disease...". – Voices of Alzheimer’s disease – Alzheimer’s association, 2008.
0 Quoherent is a cutting-edge startup pioneering the next frontier in quantum computing. Founded with a visionary spirit and a commitment…
Continuous Composites is an American company that develops CF3D composite 3D printing technology. Its technology opens new frontiers in…
UNLOcKING THE NEXT FRONTIER OF BIOLOGY. We unlock deep insights into the epigenome with EpiAmp, the first methyl-preserving amplification…
People
George Alex
Executive Officer, Director
Rudolph Tanzi
Director
Thierry Porte
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
Office address
10-50 est. staff
855 Boylston St., Boston, MA 02115